Advocates For Oral Contraceptive Switch Shop For Pharma Partner
This article was originally published in The Pink Sheet Daily & The Rose Sheet
A Center for Reproductive Rights report acknowledges work by the Oral Contraceptives Over-the-Counter Working Group, which is positioned to partner on a switch NDA through a $12m grant, and looks comprehensively at the outlook for a daily-use oral contraceptive switch.
You may also be interested in...
Birth Control Primed For Switch
A new paradigm for nonprescription approvals could eliminate the risk of self-selecting a birth control drug, with some contraindications might likely not apparent, by having pharmacists provide counseling and screening or having women use a self-assessment tool with a standard algorithm.
Bayer Relates Feeling ‘Sexy’ To Quick Relief For Allergies In Astepro Allergy Ad Campaign
Campaign featuring actress Meghann Fahy says "allergy sufferers can relieve their allergy symptoms and be more spontaneous in their romantic pursuits.” Ads launch two months after FDA granted tentative approval for two ANDAs for generic equivalents, indicating approval could come pending resolution of patent litigation.
US Infant Formula Supply Chain Strategy Delivered
FDA immediate actions include ensuring providers know they’re required to develop redundancy risk management plans, enhancing inspections of manufacturers, including by expanding and improving training for investigators, and expediting reviews of premarket submissions for new products.